Cost-effectiveness analysis of azacitidine in the treatment of high-risk myelodysplastic syndromes in Spain.
- Published in:
- Health Economics Review, 2013, v. 3, n. 1, p. 1, doi. 10.1186/2191-1991-3-28
- By:
- Publication type:
- Article
Works matching IS 21911991 AND DT 2013 AND VI 3 AND IP 1
Results: 7
1
2
Simulation model for cost estimation of integrated care concepts of heart failure patients.
- Published in:
- Health Economics Review, 2013, v. 3, n. 1, p. 1, doi. 10.1186/2191-1991-3-26
- By:
- Publication type:
- Article
3
Do health economic evaluations using observational data provide reliable assessment of treatment effects?
- Published in:
- Health Economics Review, 2013, v. 3, n. 1, p. 1, doi. 10.1186/2191-1991-3-21
- By:
- Publication type:
- Article
4
The high cost of celiac disease in an Israeli Health Maintenance Organization.
- Published in:
- Health Economics Review, 2013, v. 3, n. 1, p. 1, doi. 10.1186/2191-1991-3-23
- By:
- Publication type:
- Article
5
A cost-effectiveness analysis of respiratory syncytial virus (RSV) prophylaxis in infants in the United Kingdom.
- Published in:
- Health Economics Review, 2013, v. 3, n. 1, p. 1, doi. 10.1186/2191-1991-3-18
- By:
- Publication type:
- Article
6
Will vaccination against rotavirus infection with RIX4414 be cost-saving in Germany?
- Published in:
- Health Economics Review, 2013, v. 3, n. 1, p. 1, doi. 10.1186/2191-1991-3-27
- By:
- Publication type:
- Article
7
National health insurance, social influence and antenatal care use in Ghana.
- Published in:
- Health Economics Review, 2013, v. 3, n. 1, p. 1, doi. 10.1186/2191-1991-3-19
- By:
- Publication type:
- Article